Mr. Mick Foy
Mick Foy has been with the MHRA for more than 35 years, he is a member of the MHRA’s Senior Leadership team.
He has been manager of the Vigilance Intelligence and Research Group for 10 years and in 2019 become Head of Pharmacovigilance Strategy.
Amongst his responsibilities is to lead MHRA efforts to build PV capabilities in other countries particularly low and middle income countries as part of a global initiative with the Bill and Melinda Gates Foundation and WHO.
Mick continues to have oversight of the operation of the UK’s Yellow Card Scheme and the MHRA’s signal detection systems.
He is currently leading the MHRA’s transformation of vigilance systems with a remit to develop common IT and methodologies for medicines and devices.
Mick is Chair of the MedDRA Management Committee, and a member of the Uppsala Monitoring Centre Board.